Literature DB >> 9658071

Mouse adenovirus type 1 early region 1A is dispensable for growth in cultured fibroblasts.

B Ying1, K Smith, K R Spindler.   

Abstract

Mouse adenovirus type 1 (MAV-1) mutants with deletions of conserved regions of early region 1A (E1A) or with point mutations that eliminate translation of E1A were used to determine the role of E1A in MAV-1 replication. MAV-1 E1A mutants expressing no E1A protein grew to titers comparable to wild-type MAV-1 titers on mouse fibroblasts (3T6 fibroblasts and fibroblasts derived from Rb+/+, Rb+/-, and Rb-/- transgenic embryos). To test the hypothesis that E1A could induce a quiescent cell to reenter the cell cycle, fibroblasts were serum starved to stop DNA replication and cellular replication and then infected with the E1A mutant and wild-type viruses. All grew to equivalent titers. Steady-state levels of MAV-1 early mRNAs (E1A, E1B, E2, E3, and E4) from 3T6 cells infected with wild-type or E1A mutant virus were examined by Northern analysis. Steady-state levels of mRNAs from the mutant-infected cells were comparable to or greater than the levels found in wild-type virus infections for most of the early regions and for two late genes. The E2 mRNA levels were slightly reduced in all mutant infections relative to wild-type infections. E1A mRNA was not detected from infections with the MAV-1 E1A null mutant, pmE109, or from infections with similar MAV-1 E1A null mutants, pmE112 and pmE113. The implications for the lack of a requirement of E1A in cell culture are discussed.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9658071      PMCID: PMC109774     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  72 in total

1.  Effects of an Rb mutation in the mouse.

Authors:  T Jacks; A Fazeli; E M Schmitt; R T Bronson; M A Goodell; R A Weinberg
Journal:  Nature       Date:  1992-09-24       Impact factor: 49.962

2.  E2F: a link between the Rb tumor suppressor protein and viral oncoproteins.

Authors:  J R Nevins
Journal:  Science       Date:  1992-10-16       Impact factor: 47.728

3.  Identification of specific adenovirus E1A N-terminal residues critical to the binding of cellular proteins and to the control of cell growth.

Authors:  H G Wang; Y Rikitake; M C Carter; P Yaciuk; S E Abraham; B Zerler; E Moran
Journal:  J Virol       Date:  1993-01       Impact factor: 5.103

4.  Promoter targeting by adenovirus E1a through interaction with different cellular DNA-binding domains.

Authors:  F Liu; M R Green
Journal:  Nature       Date:  1994-04-07       Impact factor: 49.962

5.  Functional analysis of adenovirus-5 host-range deletion mutants defective for transformation of rat embryo cells.

Authors:  T Shenk; N Jones; W Colby; D Fowlkes
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1980

6.  Binding of adenovirus VA RNA to mRNA: a possible role in splicing?

Authors:  M B Mathews
Journal:  Nature       Date:  1980-06-19       Impact factor: 49.962

7.  Transcriptional repression of interleukin-6 gene by adenoviral E1A proteins.

Authors:  P M Janaswami; D V Kalvakolanu; Y Zhang; G C Sen
Journal:  J Biol Chem       Date:  1992-12-05       Impact factor: 5.157

Review 8.  DP and E2F proteins: components of a heterodimeric transcription factor implicated in cell cycle control.

Authors:  N B La Thangue
Journal:  Curr Opin Cell Biol       Date:  1994-06       Impact factor: 8.382

9.  Functional interaction of adenovirus E1A with holo-TFIID.

Authors:  T G Boyer; A J Berk
Journal:  Genes Dev       Date:  1993-09       Impact factor: 11.361

10.  The NFIII/OCT-1 binding site stimulates adenovirus DNA replication in vivo and is functionally redundant with adjacent sequences.

Authors:  L Hatfield; P Hearing
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

View more
  7 in total

1.  E1A-CR3 interaction-dependent and -independent functions of mSur2 in viral replication of early region 1A mutants of mouse adenovirus type 1.

Authors:  Lei Fang; Katherine R Spindler
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

2.  The role of mouse adenovirus type 1 early region 1A in acute and persistent infections in mice.

Authors:  K Smith; C C Brown; K R Spindler
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

Review 3.  Circumventing antivector immunity: potential use of nonhuman adenoviral vectors.

Authors:  Estrella Lopez-Gordo; Iva I Podgorski; Nicholas Downes; Ramon Alemany
Journal:  Hum Gene Ther       Date:  2014-03-25       Impact factor: 5.695

4.  Novel immunocompetent murine tumor model for evaluation of conditionally replication-competent (oncolytic) murine adenoviral vectors.

Authors:  Michael Robinson; Betty Li; Ying Ge; Derek Ko; Satya Yendluri; Thomas Harding; Melinda VanRoey; Katherine R Spindler; Karin Jooss
Journal:  J Virol       Date:  2009-02-04       Impact factor: 5.103

5.  Requirement of Sur2 for efficient replication of mouse adenovirus type 1.

Authors:  Lei Fang; Jennitte L Stevens; Arnold J Berk; Katherine R Spindler
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

Review 6.  Development of Novel Adenoviral Vectors to Overcome Challenges Observed With HAdV-5-based Constructs.

Authors:  Julio Alonso-Padilla; Tibor Papp; Győző L Kaján; Mária Benkő; Menzo Havenga; Angelique Lemckert; Balázs Harrach; Andrew H Baker
Journal:  Mol Ther       Date:  2015-10-19       Impact factor: 11.454

7.  Establishment of a Simple and Efficient Reverse Genetics System for Canine Adenoviruses Using Bacterial Artificial Chromosomes.

Authors:  Hiromichi Matsugo; Tomoya Kobayashi-Kitamura; Haruhiko Kamiki; Hiroho Ishida; Akiko Takenaka-Uema; Shin Murakami; Taisuke Horimoto
Journal:  Viruses       Date:  2020-07-16       Impact factor: 5.048

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.